JP2015517458A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517458A5 JP2015517458A5 JP2015509430A JP2015509430A JP2015517458A5 JP 2015517458 A5 JP2015517458 A5 JP 2015517458A5 JP 2015509430 A JP2015509430 A JP 2015509430A JP 2015509430 A JP2015509430 A JP 2015509430A JP 2015517458 A5 JP2015517458 A5 JP 2015517458A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- combination
- des
- human insulin
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12166251.4 | 2012-05-01 | ||
| EP12166252 | 2012-05-01 | ||
| EP12166251 | 2012-05-01 | ||
| EP12166252.2 | 2012-05-01 | ||
| US201261641544P | 2012-05-02 | 2012-05-02 | |
| US201261641540P | 2012-05-02 | 2012-05-02 | |
| US61/641,544 | 2012-05-02 | ||
| US61/641,540 | 2012-05-02 | ||
| PCT/EP2013/059073 WO2013164375A1 (en) | 2012-05-01 | 2013-05-01 | Pharmaceutical composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015517458A JP2015517458A (ja) | 2015-06-22 |
| JP2015517458A5 true JP2015517458A5 (enExample) | 2016-06-16 |
| JP6262206B2 JP6262206B2 (ja) | 2018-01-17 |
Family
ID=49514218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015509430A Active JP6262206B2 (ja) | 2012-05-01 | 2013-05-01 | 医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9884094B2 (enExample) |
| EP (1) | EP2844274B1 (enExample) |
| JP (1) | JP6262206B2 (enExample) |
| AU (1) | AU2013255880B2 (enExample) |
| BR (1) | BR112014026442A8 (enExample) |
| CA (1) | CA2872083A1 (enExample) |
| MX (1) | MX363119B (enExample) |
| RU (1) | RU2670106C2 (enExample) |
| WO (1) | WO2013164375A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090074882A1 (en) | 2005-12-28 | 2009-03-19 | Novo Nordisk A/S | Insulin compositions and method of making a composition |
| JP6049625B2 (ja) | 2010-10-27 | 2016-12-21 | ノヴォ ノルディスク アー／エス | 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療 |
| CN105188736A (zh) * | 2013-03-20 | 2015-12-23 | 诺和诺德股份有限公司 | 胰岛素给药方案 |
| WO2014177623A1 (en) * | 2013-04-30 | 2014-11-06 | Novo Nordisk A/S | Novel administration regime |
| WO2016001185A1 (en) * | 2014-07-02 | 2016-01-07 | Novo Nordisk A/S | Dosage regimen for the treatment of diabetes |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| CN114096269B (zh) | 2019-07-12 | 2024-06-11 | 诺和诺德股份有限公司 | 高浓度胰岛素制剂 |
| US20250154220A1 (en) * | 2023-11-15 | 2025-05-15 | Ambio, Inc. | Insulin analogs for the treatment of human metabolic disorder and disease |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| NZ222907A (en) | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
| HUT56857A (en) | 1988-12-23 | 1991-10-28 | Novo Nordisk As | Human insulin analogues |
| IL93282A (en) | 1989-02-09 | 1995-08-31 | Lilly Co Eli | Insulin analogues |
| WO1990013540A1 (en) | 1989-04-19 | 1990-11-15 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
| SI0792290T1 (en) | 1993-09-17 | 2001-12-31 | Novo Nordisk As | Acylated insulin |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US6531448B1 (en) * | 1997-12-23 | 2003-03-11 | Eli Lilly And Company | Insoluble compositions for controlling blood glucose |
| KR101186851B1 (ko) | 2003-08-05 | 2012-10-02 | 노보 노르디스크 에이/에스 | 신규의 인슐린 유도체 |
| KR101159559B1 (ko) | 2003-08-05 | 2012-06-26 | 노보 노르디스크 에이/에스 | 신규의 인슐린 유도체 |
| US20090074882A1 (en) | 2005-12-28 | 2009-03-19 | Novo Nordisk A/S | Insulin compositions and method of making a composition |
| EP2015770B1 (en) | 2006-05-09 | 2012-09-26 | Novo Nordisk A/S | Insulin derivative |
| WO2008152106A1 (en) | 2007-06-13 | 2008-12-18 | Novo Nordisk A/S | Pharmaceutical formulation comprising an insulin derivative |
| EP2242767A4 (en) * | 2008-02-19 | 2011-04-06 | Biocon Ltd | PROCESS FOR OBTAINING PURIFIED HETEROLOGOUS INSULINS EXPRESSED IN YEASTS |
| CA2738615A1 (en) * | 2008-10-30 | 2010-05-06 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
| SI2632478T1 (sl) * | 2010-10-27 | 2019-11-29 | Novo Nordisk As | Zdravljenje sladkorne bolezni z uporabo inzulinskih injekcij, ki se dajejo v različnih injicirnih intervalih |
-
2013
- 2013-05-01 WO PCT/EP2013/059073 patent/WO2013164375A1/en not_active Ceased
- 2013-05-01 JP JP2015509430A patent/JP6262206B2/ja active Active
- 2013-05-01 EP EP13721650.3A patent/EP2844274B1/en active Active
- 2013-05-01 BR BR112014026442A patent/BR112014026442A8/pt not_active Application Discontinuation
- 2013-05-01 MX MX2014013091A patent/MX363119B/es unknown
- 2013-05-01 AU AU2013255880A patent/AU2013255880B2/en active Active
- 2013-05-01 US US14/398,018 patent/US9884094B2/en active Active
- 2013-05-01 CA CA 2872083 patent/CA2872083A1/en not_active Withdrawn
- 2013-05-01 RU RU2014147674A patent/RU2670106C2/ru active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015517458A5 (enExample) | ||
| JP5669395B2 (ja) | 新規化合物および摂食行動に対するその効果 | |
| RU2014147674A (ru) | Фармацевтическая композиция | |
| JP2016516076A5 (enExample) | ||
| RU2011117645A (ru) | Лечение сахарного диабета с использованием инъекций инсулина с частотой менее одного раза в день | |
| JP2009533460A (ja) | ｈＧＬＰ−１、エクセンジン−４およびその類似体の医薬組成物 | |
| JP2008534622A5 (enExample) | ||
| JP2017537894A (ja) | Ｇｌｐ−１ｒおよびｇｌｐ−２ｒ二重アゴニスト活性を有する組成物及びペプチド | |
| RU2013133803A (ru) | Способы лечения метаболических нарушений и ожирения при помощи пептидов на основе глюкагона, активных по отношению к рецепторам гип и гпп | |
| CA2608311A1 (en) | Glp-1 pegylated compounds | |
| JP2010031018A5 (enExample) | ||
| JP2014504597A (ja) | アシル化グルカゴン類似体とインスリン類似体の組合せ物 | |
| RU2006144821A (ru) | Пролонгирующие метки полипептидов, содержащие тетразольную группировку | |
| JP2015110631A5 (enExample) | ||
| CN102711805A (zh) | 包含glp-1激动剂、胰岛素和甲硫氨酸的药物组合物 | |
| JP2011503152A5 (enExample) | ||
| US20150111820A1 (en) | Novel use of insulin derivatives | |
| EP1888103B1 (en) | Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling | |
| JP2024038042A (ja) | 肥満の治療および体重管理のためのｇｌｐ－１組成物 | |
| JP2014500244A5 (enExample) | ||
| CN101378775A (zh) | 对人促生长素抑制素受体亚型具有不同选择性的促生长素抑制素类似物的组合 | |
| Verge et al. | Impact of GLP-1 and GLP-1 receptor agonists on cardiovascular risk factors in type 2 diabetes | |
| RU2012126101A (ru) | Полипептидный конъюгат | |
| JP2013511287A5 (enExample) | ||
| Mikhail | Is exenatide a useful addition to diabetes therapy? |